SCHEMBL21176822

SCHEMBL21176822

CC(C)n1ccc(B2OC(C)(C)C(C)(C)O2)cc1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.37
▸ LPL P06858 9/20 0.37
▸ LIPG Q9Y5X9 9/20 0.37
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ CA4 P22748 1/20 0.35
▸ CA6 P23280 1/20 0.35
▸ CA5A P35218 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ CA5B Q9Y2D0 1/20 0.35
▸ CSF1R P07333 1/20 0.33
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20503961 0.80 PTGS1 (0.38) BACE1LPLLIPGESR2
SCHEMBL20504061 0.79 ADRA1D (0.40) BACE1LPLLIPGIRAK4
SCHEMBL2573893 0.79 LPL (0.40) LPLLIPGCA1CA2CA9
SCHEMBL30633714 0.79 CSF1R (0.37) BACE1LPLLIPGCA1CA2
SCHEMBL24145842 0.77 IDO1 (0.38) BACE1LPLLIPGCA1CA2
SCHEMBL19356313 0.77 IDO1 (0.40) BACE1LPLLIPGCA1CA2
SCHEMBL18239340 0.77 IRAK4 (0.44) BACE1LPLLIPGCA1CA2
SCHEMBL31500583 0.77 LPL (0.40) BACE1LPLLIPGCA1CA2
SCHEMBL17673204 0.77 LPL (0.40) BACE1LPLLIPGCA1CA2
SCHEMBL23370136 0.76 AOC2 (0.49) LPLLIPGCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986898-A1 EGFR INHIBITORS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-04-27 — — EP disclosed
CN-113993873-A EGFR inhibitors for the treatment of cancer 豪夫迈·罗氏有限公司 2022-01-28 — — CN disclosed
WO-2019141096-A1 SUBSTITUTED UREA COMPOUND AND PREPARATION METHOD AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2019-07-25 — — WO disclosed
Send feedback